The stock of Ampliphi Biosciences Corporation (NYSEMKT:APHB) registered an increase of 18.24% in short interest. APHB’s total short interest was 18,800 shares in March as published by FINRA. Its up 18.24% from 15,900 shares, reported previously. With 13,000 shares average volume, it will take short sellers 1 days to cover their APHB’s short positions. The short interest to Ampliphi Biosciences Corporation’s float is 0.75%. The stock is up 13.53% or $0.46 after the news, hitting $3.86 per share. About 3,076 shares traded hands. Ampliphi Biosciences Corp (NYSEMKT:APHB) has risen 6.00% since February 1, 2016 and is uptrending. It has outperformed by 10.32% the S&P500.
AmpliPhi Biosciences Corporation is a biotechnology company. The company has a market cap of $22.71 million. The Firm is focused on the discovery, development and commercialization of phage therapeutics. It currently has negative earnings. The Firm is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, drug engineering, development and manufacturing, to develop second-generation bacteriophage products.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.